©2024 Stanford Medicine
Clinical Trials Contact
About this Clinical Trial
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors